» Authors » Hirokuni Hatanaka

Hirokuni Hatanaka

Explore the profile of Hirokuni Hatanaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 168
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsugawa A, Shimizu S, Hirose D, Sato T, Hatanaka H, Takenoshita N, et al.
Psychogeriatrics . 2020 Feb; 20(4):419-426. PMID: 32017322
Aims: We performed a 12-month exercise intervention for 'nursing home for the elderly' residents requiring long-term care. We evaluated changes in their muscular strength, muscle mass, and cognitive function. Methods:...
2.
Shimizu S, Hirose D, Hatanaka H, Takenoshita N, Kaneko Y, Ogawa Y, et al.
Front Neurol . 2018 May; 9:265. PMID: 29720959
It has recently been recognized that neurodegenerative diseases are caused by common cellular and molecular mechanisms including protein aggregation and inclusion body formation. Each type of neurodegenerative disease is characterized...
3.
Tsugawa A, Ogawa Y, Takenoshita N, Kaneko Y, Hatanaka H, Jaime E, et al.
Dement Geriatr Cogn Dis Extra . 2018 Feb; 7(3):454-462. PMID: 29430248
Background/aims: Diabetes-related dementia (DrD), a dementia subgroup associated with specific diabetes mellitus (DM)-related metabolic abnormalities, is clinically and pathophysiologically different from Alzheimer disease (AD) and vascular dementia. We determined whether...
4.
Yamakawa H, Okita M, Fukasawa R, Hatanaka H, Namioka N, Hanyu H
Psychogeriatrics . 2017 Jul; 18(1):72-73. PMID: 28664625
No abstract available.
5.
Hatanaka H, Hirose D, Hirao K, Shimizu S, Kanetaka H, Hanyu H
Geriatr Gerontol Int . 2017 Jun; 17(6):1035-1037. PMID: 28635114
No abstract available.
6.
Shimizu S, Namioka N, Hirose D, Kanetaka H, Hirao K, Hatanaka H, et al.
J Neurol Sci . 2017 May; 377:50-54. PMID: 28477707
Purpose: It is widely known that there is low striatal I-FP-CIT dopamine transporter single photon emission computed tomography (DAT-SPECT) uptake in patients with dementia with Lewy bodies (DLB). However, a...
7.
Shimizu S, Hirose D, Namioka N, Kanetaka H, Hirao K, Hatanaka H, et al.
Ann Nucl Med . 2017 Apr; 31(5):390-398. PMID: 28361209
Objective: It is widely known that there is low striatal I-FP-CIT dopamine transporter-single photon emission tomography (DAT-SPECT) uptake in patients with dementia with Lewy bodies (DLB). We assessed the correlation...
8.
Hirose D, Hanyu H, Fukasawa R, Namioka N, Hatanaka H, Sato T
Geriatr Gerontol Int . 2017 Jan; 17(1):175-177. PMID: 28112496
No abstract available.
9.
Hirose D, Hanyu H, Fukasawa R, Hatanaka H, Namioka N, Sakurai H
Geriatr Gerontol Int . 2016 Nov; 16(11):1235-1236. PMID: 27870509
No abstract available.
10.
Namioka N, Hanyu H, Hirose D, Hatanaka H, Sato T, Shimizu S
Geriatr Gerontol Int . 2016 Jun; 17(6):913-918. PMID: 27296166
Aims: Dementia is closely connected with frailty, and these two conditions are common in older adults. However, the biological mechanism that causes frailty in patients with Alzheimer's disease (AD) is...